Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
RFK Jr. releases new dietary guidelines with emphasis on protein, full-fat dairy - 2Moscow: Russia well-positioned to withstand oil market shocks
- 3Weeks-Long Australian LNG Outage Will Further Tighten Supply
- 4Figure out How to Pick the Right Dental specialist for Your Dental Inserts
- 5Consumer outlook on UK economy falls to two-year low
- Monetary Freedom Guide: Plan Your Future
- Avoid Large Crowds In Bali & Swim At This Peaceful Waterfall With A Gorgeous, Natural Pool
- Best Augmented Simulation Ride: Which One Feels Generally Genuine?
- Vote In favor of Your Favored Language Interpretation Administration
- She loves to give experiences. He goes for sentimental gifts. They ask an expert: What is the perfect holiday present?
- Dental Embed Innovation: An Achievement in Helpful Dentistry
- Unraveling the Specialty of Picking Your Ideal Travel Objective
- Haifa refinery said hit in latest Iranian missile barrage
- Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns
